Fri, 17 Feb 2017 12:00:00 EST Caminamos: A Smartphone App to Connect With Walking Partners Condition: Physical Activity Intervention: Other: Caminamos App Sponsors: Klein Buendel, Inc.; Stanford University; National Institute on Minority Health and Health Disparities (NIMHD) Completed - verified February 2017
Thu, 16 Feb 2017 12:00:00 EST Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management Conditions: Ultrasonography; Nephrolithiasis Interventions: Drug: CEUS; Diagnostic Test: Non-contrast CT scan; Diagnostic Test: Capping trial Sponsors: University of California, San Francisco; Oregon Health and Science University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting - verified February 2017
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Latest Top (10) News
FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use procalcitonin (PCT), a protein associated with the body’s response to a bacterial infection, as a biomarker to help make antibiotic management decisions in patients with these conditions.
Thu, 23 Feb 2017 16:55:00 -0500 Louisiana drug and dietary supplement maker ordered to cease operations due to federal violations On Friday, U.S. District Judge Robert G. James for the U.S. District Court for the Western District of Louisiana entered a consent decree of permanent injunction against Pick and Pay Inc./Cili Minerals, a manufacturer and distributor of drugs and dietary supplements, and its owner, Anton S. Botha, requiring the business to immediately cease operations until it comes into compliance with federal laws.
Tue, 21 Feb 2017 13:00:00 -0500 FDA approves new psoriasis drug The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.
Wed, 15 Feb 2017 17:47:00 -0500 FDA approves drug to treat Duchenne muscular dystrophy The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system.
Fri, 03 Feb 2017 16:32:00 -0500 FDA confirms elevated levels of belladonna in certain homeopathic teething products The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.
Diabetes news from the American Diabetes Association
Latest Top (5) News
Diabetes news from the National Institutes of Health Diabetes Educators.
Latest Top (10) News
All content and pictures (c) MJoTA.org 2007-2017, may only be used with written permission from the publisher and named owner of the image. All maps and flags from Wikipedia unless otherwise stated. Do not copy and repost pictures or articles unless Dr Susanna and the author has given you permission. You may print and frame pictures or articles for your personal use.
Communicate with Dr Susanna on Facebook, email firstname.lastname@example.org; mail PO Box 381, Haddonfield NJ 08033; telephone 01-609-792-1571.